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In October 2007, the conference UV- 
Radiation-Induced Disease—Roles of 
UVA and UVB* was held in Stockholm, 
Sweden. Scientists, physicians, and 
industry representatives from Europe, 
the United States, and Australia gath-
ered to present and discuss current 
knowledge of the biological effects 
of UV radiation and cellular defense 
mechanisms. The conference was 
organized by Rune Toftgård and Dan 
Segerbäck (Karolinska Institutet, 
Novum, Huddinge, Sweden) and 
Johan Hansson (Karolinska Institutet, 
Stockholm, Sweden). Presentations 
encompassed three main themes: cellu-
lar effects of UV radiation, experimen-
tal models of UV-induced disease, and 
human studies of UV-induced disease. 
Special reference was made to the rela-
tive importance of short (UVB)- and 
long (UVA)-wavelength UV radiation 
and the implications for the develop-
ment of effective preventive measures. 
This report focuses on the new, unpub-
lished data presented at the meeting.
In his introduction to the confer-
ence, Rune Toftgård emphasized the 
public health importance of solar 
UV–induced disease and the problem 
of implementing preventive measures.
In the first session, on cellular effects 
of UV radiation, Alain Sarasin (Institut 
Gustave Roussy, Villejuif, France) 
described work on the polymerases 
involved in repairing UV-induced 
lesions in human cells. Examination 
of the UV mutational spectra of a 
shuttle vector replicated in Burkitt’s 
lymphoma (BL2) cells engineered spe-
cifically to knock out polymerases η, ι, 
and ζ suggested a role for polymerase ι 
in the antimutagenic bypass of specific 
UV-induced lesions.
The intricacies of the roles of heme, 
Nrf2 (an upregulator), and Bach1 (a 
downregulator) in regulating UVA-
induced heme oxygenase 1 (HO-1) 
levels in human skin fibroblasts were 
outlined by Rex Tyrrell (University of 
Bath, United Kingdom). Inhibition of 
heme synthesis by succinyl acetate 
was found to suppress UVA-induced 
accumulation of Nrf2 in the nucleus, 
suggesting that this accumulation 
results from activation mediated by 
heme release and stabilization of the 
Nrf2 protein. The refractoriness to 
reinduction of HO-1 by UVA observed 
36–48 hours after the initial induction 
may be a result of the removal of free 
heme by HO-1. Cell-labeling experi-
ments suggest that UVA radiation 
itself activates expression of Bach1 
and its nuclear export. After a second 
UVA dose, Bach1 accumulates very 
rapidly in the nucleus, probably pre-
venting reinduction of HO-1.
Further work on the cellular 
effects of UVA was reported by Jean 
Krutmann (Heinrich-Heine University, 
Düsseldorf, Germany), who used 
human skin equivalent models ('der-
mal equivalents') to examine mtDNA 
mutagenesis. Dermal equivalents from 
patients with Kearns–Sayre syndrome, 
who have an mtDNA deletion, cause 
increased contraction of collagen 
gels, indicating the increased produc-
tion of reactive oxygen species, which 
is hypothesized to result in mtDNA 
mutagenesis and aging.
Given evidence from previous work 
that pyrimidine dimers are the major 
mutagenic lesions in both UVB and 
UVA exposure and that it is the cellular 
response that differs, Thomas Rünger 
(Boston University School of Medicine, 
Massachusetts) looked at the activation 
of p53 in human fibroblasts and kerati-
nocytes. A prominent and longer-lasting 
activation was found following UVB 
treatment compared with UVA treat-
ment in both cell types. Flow cytomet-
ric analysis demonstrated early S-phase 
arrest after UVA, but early recovery and 
late S-phase arrest after UVB treatment 
of human fibroblasts. These results 
might help to explain why UVA induces 
more mutations per initial dimer load.
Gerd Pfeifer (Beckman Research 
Institute of the City of Hope, Duarte, 
California) compared the repair of 
UVA-, UVB-, and simulated sunlight 
(SSL)-induced lesions in embryonic 
fibroblasts of the BB mouse, which car-
ries cII and lacI transgenes. The oxidized 
purines induced by UVA and SSL were 
repaired within 30 minutes, whereas 
the 6-4 photoproducts and cyclobu-
tane pyrimidine dimers predominantly 
induced by UVB and SSL, but not UVA, 
persisted for 6 and 24 hours, respec-
tively. Footprinting experiments demon-
strated that UVA was weakly mutagenic 
in the cII gene, whereas UVB and SSL 
were very mutagenic, with an increase 
in the frequency of C to T transitions 
at dipyrimidine sites. Rapid repair of 
UVA-induced oxidized guanines and 
persistence of primarily UVB-induced 
cyclobutane pyrimidine dimers could 
thus explain the characteristic muta-
tions induced by sunlight.
Anna Asplund (Uppsala University, 
Sweden) described recent results in 
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transcription profiling of microdissected 
cells from basal cell carcinoma and 
normal epidermal basal cells. A total 
of 202 upregulated and 161 down-
regulated genes were reported. These 
include known genes such as Frizzled 
homolog 8, cyclooxygenase, S100 pro-
teins, and a number of 'new' genes of 
potential interest. The results are being 
validated by immunohistochemistry in 
conjunction with the Human Proteome 
Resource Project.
A urinary assay for biomonitoring of 
UV-induced DNA damage in humans, 
in which UV dimers are detected by 32P 
postlabeling, was used by Dan Segerbäck 
(Karolinska Institutet, Sweden). High 
levels of dimers were reported in the 
urine of lifeguards at a beach in south-
ern Sweden. Lower levels were found in 
parents and children going swimming 
over a weekend. Background levels of 
dimers have also been reported in the 
urine of adults not engaged in outdoor 
activities, in the summer but not in 
winter; fivefold differences were found 
between individuals.
In the second session of the meet-
ing, on experimental models of mel-
anoma, Edward De Fabo (George 
Washington University, Washington, 
DC) described work with the HGF/
SF mouse model, which after neona-
tal UV irradiation develops melanoma 
that closely resembles the human dis-
ease, with metastases. In this model, 
only UVB is effective; however, pre-
liminary data with C57BL/6 HGF/SF 
transgenic black or albino mice suggest 
that UVA can initiate melanoma in the 
former. Purification of melanocytes by 
FACS sorting in a newly derived mouse 
model system (in collaboration with 
G. Merlino and R. Zaidi, National 
Cancer Institute, National Institutes of 
Health) that has inducible melanocyte-
specific green fluorescent protein (GFP) 
expression and microarray determina-
tion of gene expression demonstrates 
specific persistent gene expression in 
UVB-treated animals that is absent 
in UVA-treated animals. The GFP 
mouse is being crossed with HGF/SF 
mice for experiments to define further 
UV-induced gene expression.
The role of melanocyte prolif-
eration and migration after neonatal 
UVR exposure is being unraveled by 
Graeme Walker (Queensland Institute 
of Medical Research, Herston, Australia) 
in melanoma-prone transgenic mice 
carrying melanocyte-specific activated 
RAS mutations, HRAS or NRAS. If 
crossed with mice carrying either a 
pRb pathway or a p53 pathway defect, 
the tumors occur earlier and are more 
aggressive. After neonatal UVB, but not 
UVA irradiation, all mice show migra-
tion of melanocytes to the epidermal 
basal layer. Ongoing work includes 
attempts to elucidate the mechanisms of 
this melanocyte response and to deter-
mine whether it plays a role in the initia-
tion of melanoma in the Ras models by 
priming melanocytes for transformation.
Graham Timmins (University of New 
Mexico, Albuquerque) described work 
supporting the hypothesis that mela-
nin has two photosensitizing roles in 
the melanosome after UV irradiation: 
direct radical damage to DNA and 
reactive melanin radical damage to 
the melanosomal membrane, result-
ing in leakage of tyrosinase-derived 
quinones and subsequent produc-
tion of bulky quinone–DNA adducts. 
B16 mouse melanoma cells are pro-
tected from SSL-induced damage by 
tyrosinase inhibitors such as methyl 
gentisate, whereas the addition of 
tyrosine increases loss of cell viability 
in this system. Tyrosine-derived DNA 
adducts were detected in SSL-treated 
B16 cells using 13C-tyrosine labeling. 
These adducts might be involved in 
the generation of T to A transversions 
in oncogenes such as BRAF. Timmins 
also discussed the experimental ani-
mal models, especially Xiphophorus 
and Monodelphis domestica, and their 
potential for melanin-mediated photo-
biology because the resistance to UV 
induction of melanoma in human albi-
nos demonstrates its importance.
Meenhard Herlyn (Wistar Institute, 
Philadelphia, Pennsylvania) described 
the isolation of multipotent stem 
cell–like cells from the dermis of 
human foreskin, their cultivation in 
vitro as spheres, and their incorpora-
tion into synthetic skin. These cells 
express neural crest and embryonal 
stem cell markers and can form mel-
anocytes after induction with appro-
priate growth factors. Comparison of 
the genomic profile of these dermal 
spheres with melanoma cell lines and 
fresh tumor specimens is expected to 
shed light on the possible role of stem 
cells in the initiation of melanoma.
Human studies of UV-induced dis-
ease were considered in the final session 
of the meeting. Julia Newton Bishop 
(University of Leeds, United Kingdom) 
reported an investigation of the interac-
tion of melanoma susceptibility genes 
with sun exposure in conjunction with 
the International Melanoma Genetics 
Consortium, GenoMel. In a newly com-
pleted study, counts of nevi, an impor-
tant risk factor for melanoma, were 
investigated in relation to holidays spent 
in sunny locations before the age of 17 
in healthy women from Yorkshire, United 
Kingdom. Ongoing meta-analyses of 
recreational and occupational sun expo-
sure and risk of melanoma indicate that 
intermittent sun exposure is causal.
A behavioral model for estimat-
ing population exposure to solar UV 
radiation was described by Brian 
Diffey (University of Newcastle, United 
Kingdom). Input data are ambient ery-
themal UV, the fraction of solar UV 
received on the face, and the frequency 
distribution of time spent outdoors. For 
northern Europe, a 1,000-fold variation 
in daily personal dose was predicted, 
with annual facial exposure of approxi-
mately 150 SED and holiday exposure 
representing approximately one-third of 
the annual dose. In contrast, in Florida, 
the daily personal dose was predicted to 
vary 200-fold, with annual facial expo-
sure of approximately 400 SED and 
holiday exposure representing approxi-
mately one-quarter of the annual dose.
Results after 14 years of follow-up 
in the Norwegian-Swedish Women’s 
Lifestyle and Health cohort study were 
reported by Marit B. Veierød (University 
of Oslo, Norway). Twofold increased 
risks of melanoma were observed for 
sunburn in childhood, the teenage 
years, and early adulthood for two 
or more sunburns per year relative 
to none in each age period. Use of a 
solarium at least once a month during 
adulthood appears to increase the risk 
of melanoma. The importance of tak-
ing into account the implementation of 
regulations concerning indoor tanning 
devices, as well as consequent changes 
in UVB/UVA ratios, was emphasized.
J Emeny et al.
Roles of UVA and UVB
 www.jidonline.org 1877
Boris Bastian (University of California, 
San Francisco) described four melano-
ma subtypes defined by the degree of 
sun damage (elastosis) in adjacent skin 
and whether the damage is mucosal or 
nonmucosal. The subtypes differed in 
genomic changes found and frequency 
of BRAF mutations. Recent genotype–
phenotype correlation studies of 302 
primary melanomas showed that BRAF 
mutations are associated with distinct 
histopathologic features. Classification 
trees can be constructed, allowing good 
prediction of mutation.
Work on gene-expression profiling 
of melanomas differing in BRAF and 
NRAS mutations was also described 
by Johan Hansson (Karolinska Institutet 
and Karolinska University Hospital, 
Sweden). A total of 79 genes were 
significantly overexpressed in BRAF 
compared with NRAS mutant tumors. 
Clustering of upregulated genes 
occurred on chromosome 7.
Antony Young (King’s College 
London, United Kingdom) presented 
data on the effects of daily suberythe-
mal SSR exposure, which more closely 
represents the real-life situation for most 
individuals. Protection against DNA 
photodamage and induction of DNA 
repair after a later high-dose SSR chal-
lenge were found in skin types that tan 
well. Young reported accumulation of 
p53 and DNA photodamage after daily 
suberythemal exposure that could be 
prevented by sunscreen application, 
but no induction of apoptosis. Loss of 
CD1a was found after daily suberythe-
mal exposure and was also prevented 
by application of a sunscreen with a 
low sun protection factor. However, 
erythema was not a useful indicator of 
immunosuppression.
In the final presentation, Marianne 
Berwick (University of New Mexico, 
Albuquerque) described the inter-
national collaborative Genes and 
Environment in Melanoma (GEM) 
study. This study of more than 3,000 
melanoma patients, which will be 
completed in 2008, is compiling data 
on properties of original biopsies, gen-
otype, and sun exposure to determine 
survival in relation to solar exposure. 
These analyses were motivated by 
the results from an earlier study that 
demonstrated that sun exposure prior 
to the diagnosis of melanoma appears 
to have a protective effect in terms of 
survival. Thus, the replication of this 
result in the GEM study would have 
important implications for the direc-
tions of future research regarding the 
mechanism underlying such an effect.
In the discussion that followed the 
presentations, the importance of study-
ing UVA and UVB in combination as 
well as separately was highlighted 
because of the uncertainty concerning 
the role of oxidative damage in UVA-
induced mutagenesis and the possibil-
ity that the cellular response might be 
crucial. Results reported at the meeting 
indicated the need for more informa-
tion on pigmentation and how it is reg-
ulated. The meeting ended with a lively 
debate on how to inform the public of 
the relative risks of UV exposure from 
sunbed use and sunny vacations.
*UV-Radiation-Induced Disease—Roles of 
UVA and UVB was held at the Nobel Forum, 
Karolinska Institutet, Stockholm, Sweden, 
18–20 October 2007. The conference 
was sponsored by the Swedish Radiation 
Protection Authority and the Swedish Cancer 
Society.
